Corrigendum to “Methyleugenol alleviates pulmonary vascular remodeling in rats with high-altitude pulmonary hypertension by improving pulmonary smooth muscle cell function” [Biomed. Pharmacother. 187 (2025) 118109] - 25/03/26
Doi : 10.1016/j.biopha.2026.119202
Yang Yu a, Yurong Wang a, Ziqi Yang a, Zhanqiang Li b, ⁎ 
, Dianxiang Lu c, ⁎ , Xingmei Nan a, ⁎
, Dianxiang Lu c, ⁎ , Xingmei Nan a, ⁎ a Department of Pharmacy, Qinghai University School of Medicine, Xining 810001, China
b Research Center for High Altitude Medicine, Laboratory for High Altitude Medicine of Qinghai Province, Key Laboratory for High Altitude Medicine (Ministry of Education), Qinghai University, Xining 810001, China
c Clinical Medical College & Affiliated Hospital of Chengdu University, 610106, China
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 197
Article 119202- avril 2026 Retour au numéro
Article précédent
- Corrigendum to “Narciclasine suppresses oral cancer metastasis by modulating cathepsin B and extracellular signal-related kinase pathways” [Biomed. Pharmacother. 158 (2023) 114159]
- Mu-Kuei Shieu, Hsin-Yu Ho, Chia-Chieh Lin, Yu-Sheng Lo, Yi-Ching Chuang, Ming-Ju Hsieh, Mu-Kuan Chen
- Corrigendum to “Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin” [Biomed. Pharmacother. 173 (2024) 116360]
- Zhenzhen Deng, Suo Qishan, Quanbin Zhang, Jing Wang, Yang Yue, Lihua Geng, Ning Wu
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?